Do SGLT-2 inhibitors exhibit similar cardiovascular benefit in patients having reduced ejection fraction heart failure with type 2 diabetes, prediabetes and normoglycemia?

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume 15, Issue 6, 2021 Nov-Dec, Article 102282 | Singh, Awadhesh Kumar; Singh, RituAbstractBackground and aimsWe aimed to know whether SGLT-2 inhibitors (SGLT-2I) exhibit similar cardiovascular (CV) benefit in patients having reduced ejection fraction heart failure (HFrEF) with varying degree of glycemia. MethodWe meta-analyzed … Source

You may also like...

Enable Notifications    OK No thanks